STATEMENT OF NEED/TARGET AUDIENCE

Oncology is one of the most rapidly evolving fields in medicine. Results presented at major cancer conferences from a plethora of ongoing clinical trials lead to the continuous emergence of new therapeutic agents and changes in the indications for existing treatments. In order to offer optimal patient care, the practicing medical oncologist must be well informed of these advances.

To bridge the gap between research and patient care, Cancer Conference Update uses one-on-one discussions with leading oncology investigators to review key clinical trial results presented at major oncology symposia. By providing access to the latest research developments and expert perspectives, this CME program assists medical oncologists in the formulation of up-to-date clinical management strategies.

LEARNING OBJECTIVES

• Summarize the rational application of emerging clinical trial data in breast cancer treatment, and incorporate these data into management strategies for patients with receptor-positive and receptor-negative disease in the neoadjuvant, adjuvant and metastatic settings.
• Describe emerging clinical trial data on localized and systemic therapies for esophageal, gastric, hepatocellular, pancreatic and colorectal cancer, and assess how this information may be applied to patient care.
• Assess the practical implications of emerging clinical trial data on therapeutic strategies for indolent and aggressive lymphoma and leukemia, and incorporate these data into existing treatment recommendations.
• Review the recent clinical trial results that demonstrate advances in localized and systemic management of head & neck and lung cancer, and integrate these findings into current treatment algorithms.
• Discuss the emerging evidence-based rationale for evolving treatment approaches to prostate, renal and urothelial cancer, and implement these practices into patient care.

PURPOSE OF THIS ISSUE OF CANCER CONFERENCE UPDATE

The purpose of Issue 3 of Cancer Conference Update is to offer the perspectives of Drs Miller, Winer, Jones, Saltz, Venook, Kahl, Kim, Lilenbaum, Vogelzang and Bukowski on the integration of data presented at the 2007 Annual Oncology Meeting in Chicago, Illinois into the management of various cancers.

ACCREDITATION STATEMENT

Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Research To Practice designates this educational activity for a maximum of 7.75 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

HOW TO USE THIS CME ACTIVITY

This CME activity contains an audio component. To receive credit, the participant should listen to the CDs, review the CME information and complete the Post-test and Evaluation Form located in the back of this book or on our website, CancerConferenceUpdate.com.

This program is supported by education grants from Abraxis BioScience, AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Genomic Health Inc and Sanofi-Aventis.